SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
杏林居士
Lv2
120 积分
2021-10-27 加入
最近求助
最近应助
互助留言
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
2个月前
已完结
Comparison of different criteria for estimating major pathological response in resectable non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy
2个月前
已完结
PD-L1 Expression and Comprehensive Molecular Profiling Predict Survival in Nonsmall Cell Lung Cancer: A Real-World Study of a Large Chinese Cohort
2个月前
已完结
Disparities in US Lung Cancer Clinical Trial Enrollment
2个月前
已完结
Tissue Age Affects Antigenicity and Scoring for the 22C3 Immunohistochemistry Companion Diagnostic Test
2个月前
已完结
Tissue Age Affects Antigenicity and Scoring for the 22C3 Immunohistochemistry Companion Diagnostic Test
2个月前
已完结
Why are surgical rates in the North of England for PS 0-2 stage I/II NSCLC lower than national average? A regional review
2个月前
已完结
Age-related treatment patterns for stage I NSCLC in three European countries
2个月前
已完结
Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients
2个月前
已完结
Prognostic value of tumor-infiltrating lymphocytes (TILs) and their association with PD-L1 expression and DNA repair protein RAD51 in patients with resected non-small cell lung carcinoma
2个月前
已关闭
没有进行任何应助
谢谢,附件为摘要,不是原文。
2个月前
重复求助【积分已退回】
2个月前
只是摘要
8个月前
不是求助文章
8个月前
速度真快
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论